Replies to post #100169 on Biotech Values

[DewDiligence]

There is no milestone payment for FDA approval of generic Lovenox. There are, however, $163M in potential milestone payments from NVS triggered by Lovenox sales thresholds and Copaxone regulatory goals and sales thresholds (#msg-44687884).